Impacts of Intermittent Fasting on Energy Balance and Associated Health Outcomes

NACompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

September 4, 2018

Study Completion Date

September 28, 2018

Conditions
ObesityType 2 Diabetes
Interventions
DEVICE

Physical Activity Monitoring (Actiheart)

Monitor physical activity using an Actiheart monitor during the required periods.

OTHER

Energy Intake Monitoring

Monitor energy intake by weighing and recording all foods/drinks consumed during the required periods.

OTHER

Body Weight Monitoring

Monitor body weight during monitoring phase to ensure stability despite other monitoring activities.

PROCEDURE

Intravenous Cannulation

Fitting of an intravenous cannula to a vein on the forearm for blood sampling during laboratory protocols.

PROCEDURE

Adipose Tissue Biopsy

This is an optional feature which if included involves the removal of a 0.5 gram sample of adipose tissue from just below the skin using a needle.

DRUG

Lidocaine Hydrochloride

The anaesthetic that will be used to numb the site of the adipose tissue biopsy in the event it is included.

OTHER

Post-Prandial Meal Tests

Consume two successive meals with regular blood samples throughout the ensuing hours (2-3 hours each).

RADIATION

DEXA Scan

Undergo a dual energy x-ray absorptiometry scan to examine body composition.

OTHER

Actiheart Calibration

Submaximal treadmill test to calibrate monitoring equipment.

OTHER

Daily Calorie Restriction

Reduce energy intake by 25% on a daily basis.

OTHER

Intermittent Fasting with Weight Loss

Alternate between 24 hour cycles of fasting and feeding with 150% of normal intake when feeding.

OTHER

Intermittent Fasting without Weight Loss

Alternate between 24 hour cycles of fasting and feeding with 200% of normal intake when feeding.

Trial Locations (1)

BA2 7AY

University of Bath, Bath

All Listed Sponsors
lead

University of Bath

OTHER

NCT02498002 - Impacts of Intermittent Fasting on Energy Balance and Associated Health Outcomes | Biotech Hunter | Biotech Hunter